
Keywords: CRC; colorectal cancer; FOBT; fecal occult blood test; CEA; carcinoembryonic antigen; AAbs; autoantibodies; TAAs; tumor-associated antigens; SLP-2; stomatin-like protein 2; PLSCR1; phospholipid scramblase 1; SEC61β; transport protein Sec61 subunit β; RP